weston family foundation
data and technology open call for proposals mobilizing data and technology to support the prevention of youth homelessness
background and objectives
researchers, service providers, advocates, and policymakers in the homelessness sector need access to timely, accurate, and comprehensive data to identify barriers and opportunities to enhance services and improve policies that contribute to homelessness prevention.
to its credit, the homelessness sector in canada has taken important steps to improve its capacity to collect, store, and access data. however, there is much more that needs to be done to:
- expand and enhance data infrastructure to harmonize and integrate data systems and platforms.
- identify and test analytical methods to improve evidence-based decision-making.
- explore the role of new technologies to predict and prevent homelessness from occurring.
to address these gaps in research and to create a space for exploration and innovation, making the shift (mts) is soliciting proposals from researchers and community organizations (who are able to hold tri-council funding) for one-time grants that respond to one of the following funding streams:
- developing a data infrastructure roadmap to support policy, operational, and research decision-making
- exploring opportunities to use data, technology, infrastructure, and new methods of data analysis to better understand and prevent youth homelessness
the purpose of this call for proposals is to develop exceptional projects that address gaps specific to the mts research agenda focusing on the prevention of youth homelessness and to complement the scope of the existing mts-funded projects. successful proposals should be designed to begin as soon as possible after notification of award. submissions may be entered by an individual or a team. priority will be given to projects that have strong partnerships and include people with lived experience of youth homelessness. matching funds in the form of cash or in-kind contributions are encouraged.
important note: for further information on eligibility, application guidelines and any specific requirements (if applicable) under each funding stream please refer to the application guide.
making the shift inc.—a youth homelessness social innovation lab – mts
translational grants
the canadian glycomics network (glyconet) is a network of centres of excellence that focuses on the role of glycans (carbohydrates) in health. areas of focus are neurodegenerative diseases, infectious diseases, chronic diseases, in particular diabetes & obesity, genetic diseases involving errors in glycan metabolism, and cancer. additional information about network research can be found at www.glyconet.ca. a key goal of glyconet is the translation of research advances into novel products for treating disease. accordingly this request for proposals seeks to fund more mature projects needing network support to de-risk and advance them to a state at which translation is possible.
request for proposals clinical partnerships – 2021–2022
idea to innovation grants
the objective of the idea to innovation (i2i) grants is to accelerate the pre-competitive development of promising technology originating from the university and college sector and promote its transfer to a new or established canadian company. the i2i grants provide funding to college and university faculty members to support research and development projects with recognized technology transfer potential. this is achieved through defined phases by providing crucial assistance in the early stages of technology validation and market connection.
idea to innovation grants
the objective of the idea to innovation (i2i) grants is to accelerate the pre-competitive development of promising technology originating from the university and college sector and promote its transfer to a new or established canadian company. the i2i grants provide funding to college and university faculty members to support research and development projects with recognized technology transfer potential. this is achieved through defined phases by providing crucial assistance in the early stages of technology validation and market connection.
canada – israel 2020-21 collaborative industrial research and development call for proposals
although this call invites proposals related to any technological or market area, special attention is being given to the following sectors:
- health and bio-sciences, including healthy ageing, mental health, biomedicine and biomedical engineering
- digital technologies, including cyber security, smart cities and smart mobility
- agricultural technologies and agri-food technologies
- clean technologies and low carbon economy technologies, including materials for clean fuels, clean transportation/mobility, climate resilient building/infrastructure, renewable energy, water and waste water management
to be considered for funding, applicants must form a project consortium and develop a collaborative research and development (r&d) project that meets the following criteria:
- the project consortium must include at least:
- 1 incorporated canadian small or medium-sized enterprise (sme), defined as a for-profit company with 500 or fewer full-time equivalent employees
- participation of canadian research institutes/universities, large enterprises and other companies are welcome as additional participants on a self-funding basis or subcontractors
- 1 eligible israeli r&d-performing company
- participation of israeli research institutes/universities are welcome as subcontractors
- 1 incorporated canadian small or medium-sized enterprise (sme), defined as a for-profit company with 500 or fewer full-time equivalent employees
- the project partners that form the consortium must:
- be capable of implementing the project including funding their respective share
- agree in advance on intellectual property rights and a commercialization strategy
- not be related in terms of corporate ownership
- the project must focus on co-developing a product, process, or technology-based service that:
- is highly innovative
- has significant commercial potential
- has outcomes that can be realized within 2 years of completion of the project, and
- does not involve r&d related to products, processes, or technological-based services with military or non-peaceful applications
- the project must demonstrate:
- the unique scientific and technological contribution that each organization brings to the project
- an obvious advantage and added value for each project partner resulting from the collaboration, such as an increased knowledge base, an access to r&d infrastructure or new fields of application or a solutions for commercial needs
- an adequate balance and significance for all project partners, defined as no more than 70% of the project budget contributed by any one organization or country
in addition to the above eligibility requirements, each applicant must meet their country-specific requirements, outlined below:
3.1 canadian eligibility requirements
canadian applicant(s) must also meet the following criteria.
- the canadian sme must have a technology that is:
- competitive in global markets, differentiated, and protectable, such as a unique or novel patentable technology that may alter the industry or market
- the canadian sme must be committed to:
- pursuing growth and profit by developing and commercializing innovative, technology-driven new or improved products, processes or technological-based services
- aggressive growth through global market expansion
- the canadian sme must be ready, and have the resources to:
- make a serious new market entry push, typically having more than 10 full-time equivalent employees and $1 million cad in annual revenue
- complete a collaborative project with international partners
team grant : preparation to trial: inflammation for chronic conditions
the objectives of this funding opportunity are:
- to promote the application of new and existing knowledge on shared pathways that drive inflammation in chronic conditions to be targeted in subsequent human intervention trials;
- to promote a precision medicine approach that equitably delivers the benefit of interventions and improves health outcomes for all individuals; and
- to promote a high quality, interdisciplinary training and mentoring environment to prepare the next generation of leaders in inflammation research